Alan Forrest

19.3k total citations · 6 hit papers
298 papers, 15.4k citations indexed

About

Alan Forrest is a scholar working on Pharmacology, Molecular Medicine and Epidemiology. According to data from OpenAlex, Alan Forrest has authored 298 papers receiving a total of 15.4k indexed citations (citations by other indexed papers that have themselves been cited), including 152 papers in Pharmacology, 100 papers in Molecular Medicine and 95 papers in Epidemiology. Recurrent topics in Alan Forrest's work include Antibiotics Pharmacokinetics and Efficacy (147 papers), Antibiotic Resistance in Bacteria (100 papers) and Pneumonia and Respiratory Infections (63 papers). Alan Forrest is often cited by papers focused on Antibiotics Pharmacokinetics and Efficacy (147 papers), Antibiotic Resistance in Bacteria (100 papers) and Pneumonia and Respiratory Infections (63 papers). Alan Forrest collaborates with scholars based in United States, Australia and United Kingdom. Alan Forrest's co-authors include Jerome J. Schentag, Mary C. Birmingham, Jian Li, Roger L. Nation, Brian T. Tsuji, Sujata M. Bhavnani, Pamela A. Moise-Broder, Charles H. Ballow, George Sakoulas and Jürgen B. Bulitta and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Clinical Infectious Diseases.

In The Last Decade

Alan Forrest

294 papers receiving 14.9k citations

Hit Papers

Pharmacodynamics of intravenous ciprofloxacin in seriousl... 1993 2026 2004 2015 1993 2004 2019 2004 2011 250 500 750
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Pharmacodynamics of intravenous ciprofloxacin in seriously ill patients
    1993 906 citations Alan Forrest, David E. Nix et al. Antimicrobial Agents and Chemotherapy profile →
  2. Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia
    2004 703 citations George Sakoulas, Pamela A. Moise-Broder et al. Journal of Clinical Microbiology profile →
  3. International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP)
    2019 637 citations Brian T. Tsuji, Jason M. Pogue et al. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy profile →
  4. Pharmacodynamics of Vancomycin and Other Antimicrobials in Patients with Staphylococcus aureus Lower Respiratory Tract Infections
    2004 589 citations Pamela A. Moise-Broder, Alan Forrest et al. profile →
  5. Population Pharmacokinetics of Colistin Methanesulfonate and Formed Colistin in Critically Ill Patients from a Multicenter Study Provide Dosing Suggestions for Various Categories of Patients
    2011 567 citations Jian Li, Visanu Thamlikitkul et al. Antimicrobial Agents and Chemotherapy profile →
  6. Antimicrobial Resistance: Pharmacokinetics‐Pharmacodynamics of Antimicrobial Therapy: It’s Not Just for Mice Anymore
    2006 547 citations Alan Forrest et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Alan Forrest United States 63 7.8k 6.3k 4.7k 3.7k 2.4k 298 15.4k
Johan W. Mouton Netherlands 71 7.3k 0.9× 5.5k 0.9× 8.1k 1.7× 6.1k 1.6× 2.0k 0.9× 353 18.6k
David C. Hooper United States 78 7.0k 0.9× 12.8k 2.0× 4.8k 1.0× 5.3k 1.4× 2.5k 1.0× 274 24.2k
George L. Drusano United States 71 12.4k 1.6× 7.2k 1.1× 7.9k 1.7× 6.8k 1.8× 3.0k 1.3× 371 20.2k
Harald Seifert Germany 65 3.4k 0.4× 12.7k 2.0× 5.7k 1.2× 5.3k 1.4× 3.2k 1.3× 282 21.6k
Harold C. Neu United States 65 6.4k 0.8× 5.6k 0.9× 4.3k 0.9× 3.2k 0.9× 1.5k 0.6× 430 17.5k
Helen Giamarellou Greece 64 4.7k 0.6× 7.5k 1.2× 4.8k 1.0× 2.0k 0.5× 1.6k 0.7× 370 14.0k
Yohei Doi United States 70 6.1k 0.8× 17.5k 2.8× 4.5k 1.0× 2.3k 0.6× 2.3k 0.9× 373 22.3k
William A. Craig United States 68 11.4k 1.5× 6.6k 1.0× 6.3k 1.3× 5.0k 1.3× 3.4k 1.4× 183 18.0k
Gian María Rossolini Italy 78 4.3k 0.5× 16.6k 2.6× 4.3k 0.9× 3.5k 1.0× 2.5k 1.0× 568 23.6k
David N. Gilbert United States 43 3.1k 0.4× 4.1k 0.6× 2.8k 0.6× 2.2k 0.6× 1.5k 0.6× 142 12.1k

Countries citing papers authored by Alan Forrest

Since Specialization
Citations

This map shows the geographic impact of Alan Forrest's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alan Forrest with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alan Forrest more than expected).

Fields of papers citing papers by Alan Forrest

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alan Forrest. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alan Forrest. The network helps show where Alan Forrest may publish in the future.

Co-authorship network of co-authors of Alan Forrest

This figure shows the co-authorship network connecting the top 25 collaborators of Alan Forrest. A scholar is included among the top collaborators of Alan Forrest based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alan Forrest. Alan Forrest is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bulitta, Jürgen B., Phillip J. Bergen, Yinzhi Lang, et al.. (2023). Distinguishing Inducible and Non-Inducible Resistance to Colistin in Pseudomonas aeruginosa by Quantitative and Systems Pharmacology Modeling at Low and Standard Inocula. Journal of Pharmaceutical Sciences. 113(1). 202–213. 2 indexed citations
2.
Olsson, Sanna, Tamara Villaverde, Lisa Pokorny, et al.. (2021). Ecological and geological processes impacting speciation modes drive the formation of wide‐range disjunctions within tribe Putorieae (Rubiaceae). Journal of Systematics and Evolution. 59(5). 915–934. 19 indexed citations
3.
Etheridge, Amy S., Deborah A. Nickerson, Nancy J. Cox, et al.. (2021). Integration of DNA sequencing with population pharmacokinetics to improve the prediction of irinotecan exposure in cancer patients. British Journal of Cancer. 126(4). 640–651. 8 indexed citations
4.
Etheridge, Amy S., Eleftheria Tsakalozou, Jacqueline Ramı́rez, et al.. (2020). Optimal Sampling Strategies for Irinotecan (CPT-11) and its Active Metabolite (SN-38) in Cancer Patients. The AAPS Journal. 22(3). 59–59. 4 indexed citations
5.
Tsuji, Brian T., Jason M. Pogue, Alexandre Prehn Zavascki, et al.. (2019). International Consensus Guidelines for the Optimal Use of the Polymyxins: Endorsed by the American College of Clinical Pharmacy (ACCP), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), Infectious Diseases Society of America (IDSA), International Society for Anti‐infective Pharmacology (ISAP), Society of Critical Care Medicine (SCCM), and Society of Infectious Diseases Pharmacists (SIDP). Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 39(1). 10–39. 637 indexed citations breakdown →
6.
Meaney, Calvin J., Benjamin M. Robinson, Alan Forrest, et al.. (2018). Definition and Validation of a Novel Metric of Erythropoiesis‐Stimulating Agent Response in Hemodialysis Patients. The Journal of Clinical Pharmacology. 59(3). 418–426. 2 indexed citations
7.
Fernández‐Mazuecos, Mario, José Luis Blanco‐Pastor, Ana Juan, et al.. (2018). Macroevolutionary dynamics of nectar spurs, a key evolutionary innovation. New Phytologist. 222(2). 1123–1138. 42 indexed citations
8.
Maifiah, Mohd Hafidz Mahamad, Darren J. Creek, Roger L. Nation, et al.. (2017). Untargeted metabolomics analysis reveals key pathways responsible for the synergistic killing of colistin and doripenem combination against Acinetobacter baumannii. Scientific Reports. 7(1). 45527–45527. 72 indexed citations
9.
Lin, Yu-Wei, Qi Zhou, Mei‐Ling Han, et al.. (2017). Elucidating the Pharmacokinetics/Pharmacodynamics of Aerosolized Colistin against Multidrug-Resistant Acinetobacter baumannii and Klebsiella pneumoniae in a Mouse Lung Infection Model. Antimicrobial Agents and Chemotherapy. 62(2). 15 indexed citations
10.
Lin, Yu-Wei, Qi Zhou, Mei‐Ling Han, et al.. (2017). Mechanism-Based Pharmacokinetic/Pharmacodynamic Modeling of Aerosolized Colistin in a Mouse Lung Infection Model. Antimicrobial Agents and Chemotherapy. 62(3). 15 indexed citations
11.
12.
Lin, Yu-Wei, Qi Zhou, Yang Hu, et al.. (2017). Pulmonary Pharmacokinetics of Colistin following Administration of Dry Powder Aerosols in Rats. Antimicrobial Agents and Chemotherapy. 61(11). 17 indexed citations
13.
Bergero, Roberta, Alan Forrest, Esther Kamau, & Deborah Charlesworth. (2007). Evolutionary Strata on the X Chromosomes of the Dioecious Plant Silene latifolia: Evidence From New Sex-Linked Genes. Genetics. 175(4). 1945–1954. 174 indexed citations
14.
Kawabe, Akira, Bengt Hansson, Jenny Hagenblad, Alan Forrest, & Deborah Charlesworth. (2006). Centromere Locations and Associated Chromosome Rearrangements in Arabidopsis lyrata and A. thaliana. Genetics. 173(3). 1613–1619. 26 indexed citations
15.
Peloquin, Charles A., Joel N. Maslow, Susan K. Mikota, et al.. (2006). Dose selection and pharmacokinetics of rifampin in elephants for the treatment of tuberculosis. Journal of Veterinary Pharmacology and Therapeutics. 29(6). 581–585. 8 indexed citations
16.
Sakoulas, George, Pamela A. Moise-Broder, Jerome J. Schentag, et al.. (2004). Relationship of MIC and Bactericidal Activity to Efficacy of Vancomycin for Treatment of Methicillin-Resistant Staphylococcus aureus Bacteremia. Journal of Clinical Microbiology. 42(6). 2398–2402. 703 indexed citations breakdown →
17.
18.
Forrest, Alan, et al.. (1994). Pharmacodynamic interactions of ciprofloxacin , piperacillin , and piperacillin/tazobactam in volunteer subjects. 34. 118. 1 indexed citations
19.
Egorin, Merrill J., David A. Van Echo, Margaret Whitacre, et al.. (1985). Human Pharmacokinetics and Correlation With Clinical Toxicities of the Anthracycline Antibiotic Menogaril (7-Omen). Journal of Bioresource Management. 26. 155. 3 indexed citations
20.
Essien‐Baidoo, Samuel, et al.. (1978). Screening for breast cancer. Report from Edinburgh Breast Screening Clinic.. BMJ. 2(6131). 175–178. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Johan W. Mouton Breakdown of academic impact, for papers by David C. Hooper Breakdown of academic impact, for papers by George L. Drusano Breakdown of academic impact, for papers by Harald Seifert Breakdown of academic impact, for papers by Harold C. Neu Breakdown of academic impact, for papers by Helen Giamarellou Breakdown of academic impact, for papers by Yohei Doi Breakdown of academic impact, for papers by William A. Craig Breakdown of academic impact, for papers by Gian María Rossolini Breakdown of academic impact, for papers by David N. Gilbert
Rankless by CCL
2026